| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/08/2007 | US20070031443 Methods for treating or preventing skin disorders using CD2-binding agents |
| 02/08/2007 | US20070031440 Modified transferin-antibody fusion proteins |
| 02/08/2007 | US20070031439 Novel protein related to melanoma-inhibiting protein and uses thereof |
| 02/08/2007 | US20070031438 Antibodies as chimeric effector cell receptors against tumor antigens |
| 02/08/2007 | US20070031437 Compositions and methods for modulating vascular development |
| 02/08/2007 | US20070031436 Bivalent monomeric Fv antibody formed by one single-chain Fv monomer having four variable domains; expression plasmids which code for an Fv antibody; diagnosis; stability; no undesired immune response; side effect reduction; lack constant domains |
| 02/08/2007 | US20070031435 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 02/08/2007 | US20070031434 Uses for Eph receptor antagonists and agonists |
| 02/08/2007 | US20070031433 Tumor antigen |
| 02/08/2007 | US20070031432 Tumor antigen |
| 02/08/2007 | US20070031431 polypeptides consisting of amino acid sequences or peptide fragments and drug carriers, used for inducing and/or activating human leukocyte antigens (HLA-A2)-restricted tumor-specific cytotoxic T lymphocytes; anticancer vaccines |
| 02/08/2007 | US20070031430 Varible domain of heavy chain antibodies; antitumor agents |
| 02/08/2007 | US20070031429 Cancerous desease modifying antibodies |
| 02/08/2007 | US20070031428 Isolated monoclonal antibody produced by hybridoma deposit IDAC accession number 170505-01; binding assays; customization of therapy for each individual |
| 02/08/2007 | US20070031427 Cancerous disease modifying antibodies |
| 02/08/2007 | US20070031426 Isolated monoclonal antibody produced by hybridoma deposit IDAC accession number 170505-03; binding bioassays; customization of therapy designed for each individual; anticarcinogenic-, -tumor and -metastasis agents |
| 02/08/2007 | US20070031425 Cancerous disease modifying antibodies |
| 02/08/2007 | US20070031424 Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof |
| 02/08/2007 | US20070031423 inhibiting proliferation of a antigenmyeloma tumor cell expressing a ganglioside by contacting the cell with an antibody that specifically binds to the ganglioside; melanoma, myeloma, small cell lung cancer, thymic lymphoma, T-cell lymphoma, B-cell lymphoma, osteosarcoma, and acute T-cell leukemia |
| 02/08/2007 | US20070031422 Selection of cells expressing heteromeric polypeptides |
| 02/08/2007 | US20070031421 Inhibitors targeting osteoclast-associated protein |
| 02/08/2007 | US20070031420 MASP-2, a complement-fixing enzyme, and uses for it |
| 02/08/2007 | US20070031417 Dicer interacting proteins and uses therefor |
| 02/08/2007 | US20070031416 Use of antibody |
| 02/08/2007 | US20070031415 Regulation of interaction between rapl and rap1 |
| 02/08/2007 | US20070031414 DR5 antibodies and uses thereof |
| 02/08/2007 | US20070031413 Treatment with anti-vegf antibodies |
| 02/08/2007 | US20070031411 Vaccine comprising a tick cement protein |
| 02/08/2007 | US20070031410 POP2: NFkB - Inhibiting Polypeptides, Nucleic Acids and Methods of Use |
| 02/08/2007 | US20070031409 Recombinant DNA-molecule complex for the expression of anti-human-interferon-gamma chimeric antibodies or antibody fragments |
| 02/08/2007 | US20070031408 Treating a subject afflicted with HIV-1 by administering anti-viral agent selected from a nonnucleoside reverse transcriptase inhibitor, a nucleoside reverse transcriptase inhibitor, a HIV-1 protease inhibitor, and a HIV-1 fusion or viral entry inhibitor |
| 02/08/2007 | US20070031407 Peptide or protein containing a C'-D loop of the CD28 receptor family |
| 02/08/2007 | US20070031406 Anti-thymocyte antiserum and use thereof to trigger b cell apoptosis |
| 02/08/2007 | US20070031405 Use of A33 antigens and jam-it |
| 02/08/2007 | US20070031404 Antibodies |
| 02/08/2007 | US20070031395 Repressor of skeletal muscle differentiation, nucleic acid coding therefor and the use thereof in diagnosis and therapy |
| 02/08/2007 | US20070031377 Treatment of type 1 immune response-mediated inflammatory lung disease by modulation of ifn-gamma activity |
| 02/08/2007 | US20070031375 IL-16 antagonist peptides and DNA encoding the peptides |
| 02/08/2007 | US20070031335 Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers |
| 02/08/2007 | US20070031331 Treatment of Disorders |
| 02/08/2007 | US20070031330 Isolated monoclonal antibody produced by the hybridoma; primary tumors and tumor metastases |
| 02/08/2007 | CA2620937A1 Cancerous disease modifying antibodies |
| 02/08/2007 | CA2618050A1 Antibodies directed against an ldl receptor |
| 02/08/2007 | CA2618044A1 Antibodies directed against a ldl receptor |
| 02/08/2007 | CA2617462A1 Cancerous disease modifying antibodies |
| 02/08/2007 | CA2617458A1 Cancerous disease modifying antibodies |
| 02/08/2007 | CA2617454A1 Cancerous disease modifying antibodies |
| 02/08/2007 | CA2617447A1 Cancerous disease modifying antibodies |
| 02/08/2007 | CA2617446A1 Cancerous disease modifying antibodies |
| 02/08/2007 | CA2616898A1 Cd33-specific single-chain immunotoxin and method of use |
| 02/07/2007 | EP1749889A1 Leader peptides for enhancing secretion of recombinant protein from a host cell |
| 02/07/2007 | EP1749888A2 Soluble zalpha11 cytokine receptors |
| 02/07/2007 | EP1749886A2 Polypeptides having kinase activity, their preparation and use |
| 02/07/2007 | EP1749840A2 Recombinant il-5 antagonists useful in treatment of il-5 mediated disorders |
| 02/07/2007 | EP1749839A1 Antigen binding polypeptides against F4(K88) fimbriae |
| 02/07/2007 | EP1749836A2 Recombinant vascular endothelial cell growth factor D (VEGF-D) |
| 02/07/2007 | EP1749538A1 Methods of inducing differentiation of regulatory t-cells and proliferating the same with gpi anchor protein agonist and medicinal composition therefor |
| 02/07/2007 | EP1749537A1 Anti-idiotypics antibodies having a neutralising activity against factor VIII inhibitor antibody |
| 02/07/2007 | EP1749210A2 Isolation of allergen-specific immunoglobulin genes from human b-cells from atopy sufferers |
| 02/07/2007 | EP1749102A2 Transgenic animals and uses thereof |
| 02/07/2007 | EP1749031A2 Methods for reducing biofilm formation in infectious bacteria |
| 02/07/2007 | EP1749030A1 A diabody which specifically binds streptococcus surface antigen i/ii and methods of use thereof |
| 02/07/2007 | EP1749029A2 Binding molecules capable of neutralizing rabies virus and uses thereof |
| 02/07/2007 | EP1749027A2 Gene products expressed differentially in tumors and use thereof |
| 02/07/2007 | EP1748689A2 Non human transgenic animal as a model of neurodegenerative diseases and for the early diagnosis thereof |
| 02/07/2007 | EP1272609B1 Single chain antibody against mutant p53 |
| 02/07/2007 | EP1218491B1 Dna encoding a human subunit 5-ht3-c of the 5-ht3 serotonin receptor |
| 02/07/2007 | EP1141308B1 Group b streptococcus proteins, and their use |
| 02/07/2007 | EP0939810B1 Transcriptional intermediary factor-2 tif2 |
| 02/07/2007 | EP0909272B1 Helicobacter pylori adhesin binding group antigen |
| 02/07/2007 | EP0833906B1 Novel ctla4/cd28 ligands and uses therefor |
| 02/07/2007 | EP0504363B2 PURIFIED IgG ANTIBODIES |
| 02/07/2007 | CN1910456A Marker for neuromyelitis optica |
| 02/07/2007 | CN1910293A Detection of mutations in a gene associated with resistance to viral infection, OASI |
| 02/07/2007 | CN1910200A Homogeneous preparations of IL-28 and IL-29 |
| 02/07/2007 | CN1909921A Compositions for reducing bacterial carriage and cns invasion and methods of using same |
| 02/07/2007 | CN1908170A Lim mineralization protein splice variants |
| 02/07/2007 | CN1908014A Modified peptides as therapeutic agents |
| 02/07/2007 | CN1908013A Anti-alphavbeta6 antibodies |
| 02/07/2007 | CN1908012A Cell surface molecule mediating cell adhesion and signal transmission |
| 02/07/2007 | CN1908006A Method of fast purifying and preparing Fab fragment antibody |
| 02/07/2007 | CN1908004A Purification of nasopharyngeal carcinoma related gene UBAP1 coding protein and preparation of antibody thereof |
| 02/06/2007 | US7173118 Nogo receptor homologs |
| 02/06/2007 | US7173115 Nucleotide sequences coding polypeptides for use in the diagnosis and treatment of cancer |
| 02/06/2007 | US7173112 Antibody to GALP and uses thereof |
| 02/06/2007 | US7173000 Modified factor VIIa |
| 02/06/2007 | US7172898 Not expressed in normal adult tissue, but is highly expressed in prostate tissue xenografts |
| 02/06/2007 | US7172892 Exhibit protease activity as a single chain or as an activated two chain form; use of polypeptides to identify compounds that modulate the protease activity thereof and as tumor markers |
| 02/06/2007 | US7172873 Methods of detecting early renal disease in animals |
| 02/06/2007 | US7172871 Methods and compositions for modulating axonal outgrowth of central nervous system neurons |
| 02/06/2007 | US7172869 Increasing expression of exogenous nucleotide sequences via lymphocyte activation prior to gene transfer to cells |
| 02/06/2007 | US7172759 Agonist anti-CD40 molecules, including monoclonal antibodies, which can bind to and stimulate professional and non-professional human antigen-presenting cells; may be useful as antitumor agents |
| 02/06/2007 | US7172758 Reducing occurrence of occlusions following treatment for arterial atherosclerotic disease; injecting into the blood-stream , prior to performing the angioplasty, a quantity of a bispecific antibody with two antigen binding sites |
| 02/06/2007 | US7172750 Compositions and methods for the treatment and diagnosis of immune disorders |
| 02/06/2007 | CA2389742C Plant photoperiod sensitivity gene and use of the same |
| 02/06/2007 | CA2166479C Density enhanced protein tyrosine phosphatases |
| 02/04/2007 | CA2551317A1 Anti-idiotypic antibody neutralizing the inhibitory action of an inhibitory antibody for factor viii |
| 02/01/2007 | WO2007014170A2 Compositions and methods for protein deaggregation |
| 02/01/2007 | WO2007014169A2 Anti-cd26 antibodies and methods of use thereof |
| 02/01/2007 | WO2007014162A2 Multiple gene expression including sorf constructs and methods with polyproteins, pro-proteins, and proteolysis |